About Us | Contact

Gerald Steven Falchook Investigator

Presbyterian St Luke's Medical Center NPI1366541294
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$51,108.20
from 62 payments in the last 6 years

Total Cash or Cash Equivalent

$37,315.30
from 29 payments in the last 6 years

Total In-kind Items & Services

$13,792.90
from 33 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
11/10/2021 General (Non-Research) In-kind items and services Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $556.10 Details
Payment from Boehringer Ingelheim International GmbH
Payment Record ID 840781119
11/10/2021 General (Non-Research) In-kind items and services Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $695.13 Details
Payment from Boehringer Ingelheim International GmbH
Payment Record ID 840781099
09/20/2021 General (Non-Research) In-kind items and services Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2094.01 Details
Payment from Boehringer Ingelheim International GmbH
Payment Record ID 822295443
12/17/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2620.00 Details
Payment from Regeneron Healthcare Solutions, Inc.
Payment Record ID 809576373
02/11/2021 Research In-kind items and services $480.92 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A PHASE 1/2 STUDY OF REGN5678 (ANTI-PSMAXCD28) WITH CEMIPLIMAB (ANTI-PD-1) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Clinical Trials Gov ID NCT03972657
Payment Record ID 793082349
12/10/2020 Research In-kind items and services $45.64 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study A PHASE 1/2 STUDY OF REGN5678 (ANTI-PSMAXCD28) WITH CEMIPLIMAB (ANTI-PD-1) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Clinical Trials Gov ID NCT03972657
Payment Record ID 724432525
09/09/2020 Research In-kind items and services Biological $868.37 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study LIBTAYO CLINICAL PUBLICATION PROGRAM
Payment Record ID 724432519
01/22/2020 Research In-kind items and services Biological $1087.29 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study LIBTAYO CLINICAL PUBLICATION PROGRAM
Payment Record ID 724432507
10/10/2019 Research In-kind items and services $273.64 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study MASTER PROTOCOL TO ASSESS THE SAFETY AND ANTITUMOR ACTIVITY OF GENETIC
Payment Record ID 709081891
10/10/2019 Research In-kind items and services $181.98 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study MASTER PROTOCOL TO ASSESS THE SAFETY AND ANTITUMOR ACTIVITY OF GENETIC
Payment Record ID 709080765
06/01/2019 General (Non-Research) In-kind items and services Food and Beverage $107.65 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 685798067
07/12/2019 General (Non-Research) In-kind items and services Food and Beverage $13.62 Details
Payment from PFIZER INC.
Payment Record ID 672337476
10/10/2019 Research In-kind items and services $18.60 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study MASTER PROTOCOL TO ASSESS THE SAFETY AND ANTITUMOR ACTIVITY OF GENETIC
Payment Record ID 669974539
10/10/2019 Research In-kind items and services $89.05 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study MASTER PROTOCOL TO ASSESS THE SAFETY AND ANTITUMOR ACTIVITY OF GENETIC
Payment Record ID 669971007
10/10/2019 Research In-kind items and services $167.63 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study MASTER PROTOCOL TO ASSESS THE SAFETY AND ANTITUMOR ACTIVITY OF GENETIC
Payment Record ID 669967467
10/10/2019 Research In-kind items and services $23.22 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study MASTER PROTOCOL TO ASSESS THE SAFETY AND ANTITUMOR ACTIVITY OF GENETIC
Payment Record ID 669967081
10/10/2019 Research In-kind items and services $127.95 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study MASTER PROTOCOL TO ASSESS THE SAFETY AND ANTITUMOR ACTIVITY OF GENETIC
Payment Record ID 669964537
05/31/2019 General (Non-Research) In-kind items and services Food and Beverage $24.99 Details
Payment from Amgen Inc.
Payment Record ID 663332085
04/23/2018 General (Non-Research) Cash or cash equivalent Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1807.92 Details
Payment from Incyte Corporation
Payment Record ID 593974170
01/23/2018 General (Non-Research) Cash or cash equivalent Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $399.30 Details
Payment from Incyte Corporation
Payment Record ID 593974159
11/21/2018 General (Non-Research) In-kind items and services Food and Beverage $15.31 Details
Payment from Foundation Medicine, Inc.
Payment Record ID 585909085
03/21/2018 General (Non-Research) In-kind items and services Food and Beverage $14.41 Details
Payment from Foundation Medicine, Inc.
Payment Record ID 585909081
02/13/2018 Research Cash or cash equivalent $20792.00 Details
Payment from Eli Lilly and Company
Paymment Research Study A PHASE 1A-1B TRIAL INVESTIGATING THE CSF-1R INHIBITOR LY3022855 IN COMBINATION WITH DURVALUMAB -MEDI4736- OR TREMELIMUMAB IN PATIENTS WITH ADVANCED SOLID TUMORS
Clinical Trials Gov ID NCT02718911
Payment Record ID 585602289
12/10/2018 Research Cash or cash equivalent Biological $97.65 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study Libtayo Clinical Publication Program
Payment Record ID 577362386
12/10/2018 Research Cash or cash equivalent Biological $83.27 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study Libtayo Clinical Publication Program
Payment Record ID 577362379
10/01/2018 Research Cash or cash equivalent Biological $229.45 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study Libtayo Clinical Publication Program
Payment Record ID 577362373
10/01/2018 Research Cash or cash equivalent Biological $299.45 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study Libtayo Clinical Publication Program
Payment Record ID 577362365
09/26/2018 Research Cash or cash equivalent Biological $23.87 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study Libtayo Clinical Publication Program
Payment Record ID 577362363
09/26/2018 Research Cash or cash equivalent Biological $22.68 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study Libtayo Clinical Publication Program
Payment Record ID 577362357
07/01/2018 Research Cash or cash equivalent Biological $90.26 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study Libtayo Clinical Publication Program
Payment Record ID 577362347
07/01/2018 Research Cash or cash equivalent Biological $90.26 Details
Payment from Regeneron Pharmaceuticals, Inc.
Paymment Research Study Libtayo Clinical Publication Program
Payment Record ID 577362345
06/01/2018 General (Non-Research) In-kind items and services Food and Beverage $69.46 Details
Payment from AbbVie, Inc.
Payment Record ID 571617387
06/03/2018 Research In-kind items and services $69.96 Details
Payment from AbbVie, Inc.
Payment Record ID 566856829
06/01/2018 General (Non-Research) In-kind items and services Food and Beverage $47.02 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 561917525
11/07/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $4500.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Payment Record ID 488560909
10/06/2017 General (Non-Research) Cash or cash equivalent Food and Beverage $17.99 Details
Payment from E.R. Squibb & Sons, L.L.C.
Payment Record ID 488560907
10/06/2017 General (Non-Research) Cash or cash equivalent Food and Beverage $56.44 Details
Payment from E.R. Squibb & Sons, L.L.C.
Payment Record ID 488560905
10/06/2017 General (Non-Research) Cash or cash equivalent Food and Beverage $9.41 Details
Payment from E.R. Squibb & Sons, L.L.C.
Payment Record ID 488560903
10/06/2017 General (Non-Research) Cash or cash equivalent Food and Beverage $30.97 Details
Payment from E.R. Squibb & Sons, L.L.C.
Payment Record ID 488560901
10/06/2017 General (Non-Research) Cash or cash equivalent Food and Beverage $19.59 Details
Payment from E.R. Squibb & Sons, L.L.C.
Payment Record ID 488560899
10/05/2017 General (Non-Research) Cash or cash equivalent Education $3.64 Details
Payment from E.R. Squibb & Sons, L.L.C.
Payment Record ID 488560897
10/05/2017 General (Non-Research) Cash or cash equivalent Food and Beverage $2.18 Details
Payment from E.R. Squibb & Sons, L.L.C.
Payment Record ID 488560895
06/27/2017 Research In-kind items and services $3213.10 Details
Payment from Eli Lilly and Company
Paymment Research Study EFFECTS OF MULTIPLE DOSES OF ABEMACICLIB ON THE PHARMACOKINETICS OF CYTOCHROME P450 -CYP- 1A2, CYP2C9, CYP2D6, AND CYP3A SUBSTRATES -CAFFEINE, WARFARIN, DEXTROMETHORPHAN, AND MIDAZOLAM- IN CANCER PATIENTS
Clinical Trials Gov ID NCT02688088
Payment Record ID 457097017
04/25/2017 Research In-kind items and services $2602.10 Details
Payment from Eli Lilly and Company
Paymment Research Study A PHASE 1A-1B TRIAL INVESTIGATING THE CSF-1R INHIBITOR LY3022855 IN COMBINATION WITH DURVALUMAB -MEDI4736- OR TREMELIMUMAB IN PATIENTS WITH ADVANCED SOLID TUMORS
Clinical Trials Gov ID NCT02718911
Payment Record ID 457097015
06/02/2017 General (Non-Research) In-kind items and services Food and Beverage $47.70 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 444805675
11/03/2017 General (Non-Research) In-kind items and services Food and Beverage $14.26 Details
Payment from Foundation Medicine, Inc.
Payment Record ID 437161527
06/09/2017 General (Non-Research) In-kind items and services Food and Beverage $15.99 Details
Payment from Foundation Medicine, Inc.
Payment Record ID 437161525
06/03/2016 General (Non-Research) In-kind items and services Food and Beverage $76.59 Details
Payment from Genentech, Inc.
Payment Record ID 402898146
09/15/2016 General (Non-Research) In-kind items and services Food and Beverage $34.60 Details
Payment from Celgene Corporation
Payment Record ID 401573150
03/17/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $5000.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Payment Record ID 398529459
02/26/2016 General (Non-Research) Cash or cash equivalent Travel and Lodging $490.59 Details
Payment from E.R. Squibb & Sons, L.L.C.
Payment Record ID 398499456
02/26/2016 General (Non-Research) Cash or cash equivalent Travel and Lodging $224.02 Details
Payment from E.R. Squibb & Sons, L.L.C.
Payment Record ID 398499208
02/27/2016 General (Non-Research) Cash or cash equivalent Food and Beverage $114.46 Details
Payment from E.R. Squibb & Sons, L.L.C.
Payment Record ID 398498988
02/27/2016 General (Non-Research) Cash or cash equivalent Food and Beverage $51.75 Details
Payment from E.R. Squibb & Sons, L.L.C.
Payment Record ID 398498720
02/27/2016 General (Non-Research) Cash or cash equivalent Food and Beverage $24.24 Details
Payment from E.R. Squibb & Sons, L.L.C.
Payment Record ID 398498392
02/26/2016 General (Non-Research) Cash or cash equivalent Food and Beverage $41.68 Details
Payment from E.R. Squibb & Sons, L.L.C.
Payment Record ID 398498116
02/26/2016 General (Non-Research) Cash or cash equivalent Food and Beverage $125.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Payment Record ID 398497834
06/04/2016 Research In-kind items and services $65.08 Details
Payment from Millennium Pharmaceuticals, Inc.
Paymment Research Study Phase 2 Study of MLN0128, Combination of MLN0128 With MLN1117, Paclitaxel and Combination of MLN0128 With Paclitaxel in Women With Endometrial Cancer
Clinical Trials Gov ID NCT02725268
Payment Record ID 397535684
06/04/2016 General (Non-Research) Cash or cash equivalent Food and Beverage $47.23 Details
Payment from E.R. Squibb & Sons, L.L.C.
Payment Record ID 397444716
06/30/2016 Research In-kind items and services $541.36 Details
Payment from Eli Lilly and Company
Paymment Research Study A PHASE 1A-1B TRIAL INVESTIGATING THE CSF-1R INHIBITOR LY3022855 IN COMBINATION WITH DURVALUMAB -MEDI4736- OR TREMELIMUMAB IN PATIENTS WITH ADVANCED SOLID TUMORS
Clinical Trials Gov ID NCT02718911
Payment Record ID 372519766
06/14/2016 General (Non-Research) In-kind items and services Food and Beverage $67.57 Details
Payment from Regeneron Pharmaceuticals, Inc.
Payment Record ID 366365280
04/17/2016 General (Non-Research) In-kind items and services Food and Beverage $42.60 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 363449294
;